# Alcon to acquire STAAR Surgical for $1.6 billion

Alcon announced an amended merger agreement to acquire STAAR Surgical Company for $30.75 per share in cash, representing a total equity value of approximately $1.6 billion. The transaction follows a go-shop period that expired on December 6, 2025.

- Type: Acquisition
- Announced: 2025-12-09
- Where: United States
- Value: $1.60B
- Status: announced
- Products: phakic IOLs, EVO Implantable Collamer Lenses
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Alcon Group](https://endata.com/companies/16712.md) (acquirer)
- [STAAR Surgical](https://endata.com/companies/86423.md) (target)

## Sources

- [alcon.com](https://www.alcon.com/media-release/alcon-announces-amended-merger-agreement-staar-surgical/), 2025-12-09: "The amended transaction provides tremendous value to STAAR stockholders and we are pleased to have reached this agreement."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.